The development of diagnostic techniques and an awareness of health examinations can bring about an early diagnosis of lung cancer. However, appropriate postoperative management and adjuvant chemotherapy remain under debate in postoperative therapeutic strategy. The present study was conducted to assess the clinicopathologic factors that influence recurrence and prognosis after complete resection of lung cancer. Methods: The present study analyzed 62 patients with lung cancer who underwent complete resection of diagnosed adenocarcinoma between 1994 and 2007. In addition to conventional factors, which include staging factor and histological evaluation, the present study also performed univariate and multivariate analyses to consider claudin, a cell adhesion molecule, as a prognostic factor by immunohistochemical staining. Results: There was no correlation between conventional factors, including lymphatic and vascular invasion, and recurrence. However, there was a significant correlation between high expression of claudin 4 and cancer recurrence. In particular, there was a correlation between high expressions of claudin 1, 4, and 5 and a reduction of disease-free survival. Conclusion: Increased expressions of claudin 4 were negative prognostic factors in adenocarcinoma of the lung and thus could be used to identify high-risk patients for adjuvant chemotherapy, even if they had early-stage lung cancer. The present findings collectively suggest that consideration of claudin as a prognostic factor in the active postoperative treatment in patients at high risk will lead to better therapeutic outcomes with fewer side effects.
INTRODUCTION
Lung cancer is the leading cause of cancer death. There have been histological, molecular, and genetic mutation studies aimed at increasing the survival rate and reducing the recurrence rate after lung cancer treatment [1] [2] [3] [4] . More recently, studies on cell adhesion molecules (CAMs) have been in progress.
CAMs are proteins at the junction between cells. These proteins participate in the adhesion and transport of molecules between cells, which contribute to maintaining cell homeostasis when exposed to various conditions. In addition, CAMs − 263 − participate in cell growth as well as cell cycle control, and loss of function in these junctions due to abnormalities in CAMs can cause pathological states. Studies based on the expression level of these proteins are being conducted for various cancer prognosis factors [5] . One of them is claudin, which consists of 24 transmembrane proteins, which exists at the tight junction of epithelial and endothelial cells [6, 7] .
Functions of claudin are structural maintenance of the junction, paracellular permeability control, maintenance of cell polarity, and other basic defense systems. Claudin is over-or underexpressed in pathological status although it is normally observed in normal tissues such as lung epithelial cells [8] . In addition, they affect tumerogenesis, recurrence, and metastasis by participating in cell cycle control and intracellular signaling through interaction between factors in the cytoplasm or the nucleus [9] .
Since not all cancer patients have recurrence after complete resection, selective adjuvant treatment after surgery is necessary. Through careful evaluation of risk factors suggesting poor prognosis after surgery, selective adjuvant treatment among the high-risk group will be possible, which will lead to reduction of complications and enhanced curative effect.
The authors in this study focus on factors that affect recurrence and prognosis in patients after complete resection. 
2) Production of tissue microarray block
Formalin-fixed, paraffin-embedded tissue samples were for tissue microarray (TMA). Representative areas of each tumor were marked on each hematoxylin and eosin-stained slide, and the corresponding area of the tissue blocks was sampled.
The designated area of each donor block was collected using a tissue cylinder punch (diameter, 3 mm), and the samples were transferred to a recipient block.
3) Immunohistochemical staining
Sections (thickness, 4 μm) from TMAs were cut from 10% formalin buffer, embedded in paraffin, mounted onto 2, ＞10% and ≤50%; and 3, ＞50%). Samples were consid- Values are presented as mean±standard deviation or number (%).
ered positive for claudin staining intensity of ＞1 (moderate to strong), and ＞50% of the cells were positive.
4) Statistical analysis
The 
RESULTS

1) General characteristics of the patient group
The median follow-up time for all patients was 1,518.8± (Table 4) . A survival analysis between recurrence and claudin expression levels was done with the Kaplan-Meier method (Figs. 1-3 ).
DISCUSSION
The increasing occurrence of cancer is a worldwide phenomenon, and among them, lung cancer is a major cause of death due to cancer. There are many ongoing studies on the improvement of the prognosis and treatment result [10] . This study shows that the pathologic stage is related to recurrence.
The TNM staging system is a typical index for comprehending the prognosis, and studies on this system are in progress.
In particular, the 2012 National Comprehensive Cancer
Network guideline suggests chemotherapy after surgery in case of non-small lung cell carcinoma in stage IB for the high-risk group, where the high-risk group is referred as that of patients who have poorly differentiated tumor, vessel invasion, visceral pleura invasion, and tumor size of more than 4 cm [11] . If studies on factors affiliated with the high-risk group are continued, better prognosis are expected by deciding the implementation of pre-or post-surgery chemotherapy and radiation therapy through an accurate understanding of the high-risk group.
Molecular biological approaches are also being pursued, and one of them is the study of a protein that exists in the intracellular junction. Claudin is a protein that exists in a tight junction that plays an important role in maintaining a cell's polarity and paracellular transport [6, 7] . Claudin exists normally in normal cells, but in a distressed cell condition, it is often over-or underexpressed [8] . Claudin expression differs for various types of tumors, and even tumors that occur in the same organ show a difference in Claudin expression in different tissues. Therefore, claudin expression not only affects the accuracy of the diagnosis but is also an important index for prognosis [12] . In lung cancer, claudin 1 is expressed the most in squamous cell carcinoma and claudin 4
and 5 are expressed the most in adenocarcinoma [13] . In addition, the overexpression of claudin 1 is observed in the cas- through an extracellular loop [19] . Claudin expression has also been associated with the activation of matrix metalloproteinase, which involved cell migration via degradation of the extracellular matrix [20] . These mechanisms may play a role in the recurrence and metastasis of a tumor. In order to clarify the relationship between claudin and recurrence, an additional molecular biological study is required.
The prognosis analysis of tumor using the degree of claudin expression is still not clear, particularly in the case of claudin 4, which is expressed in lung cancer. Thus, precise comprehension of the prognosis correlation and mechanism is needed, and further research and experiments are also necessary. Efforts to find various prognostic factors will lead to better studies that will enable a more selective and aggressive treatment before and after surgery by precisely categorizing the high-risk group by using a poor prognosis factor, and will improve tumor treatment on the whole.
In conclusion, this study suggests that the overexpression of claudin 4 is associated with poor disease-free survival and is identified as a high risk factor in lung adenocarcinoma.
Further study on claudin is necessary to identify it as a prognostic factor in lung cancer.
